Rare disease news

FDA approvals, research breakthroughs, clinical trials, and advocacy updates

Curated and summarized by AI for patients and caregivers

🔍
AllDrug approvalsClinical trialsResearchGrants & fundingAdvocacy & policyPipeline
Show:All newsBreaking onlyImportant & breaking
Date:7 days30 days90 daysAll time

1 article from the last 30 days matching "advanced cancer"

Clinical trialUNITERARE2 days ago

New Recruiting Trial: Biofeedback-Assisted Pelvic Floor Rehabilitation for Radiation-Induced Sexual Dysfunction in Cervical Cancer Survivors

Researchers are testing a new treatment to help cervical cancer survivors who have sexual problems after radiation therapy. The treatment uses biofeedback—a technique that helps you learn to control your pelvic floor muscles—combined with physical rehabilitation exercises. This trial is now accepting patients to see if this approach can improve sexual function and quality of life.

WHY IT MATTERSThis trial directly addresses a common but often overlooked side effect of cervical cancer treatment, offering cervical cancer survivors a non-medication option to restore sexual function after radiation therapy.
You can act on thiscervical cancerradiation-induced sexual dysfunction

Get personalized rare disease news

Follow your conditions to see news about the diseases that matter to you — FDA approvals, trial openings, and research breakthroughs.

Create free account →Browse diseases